Flinders University Flinders Academic Commons

Flinders Academic Commons >
Research Publications >
ERA 2010 >
07 - Biomedical and Clinical Research >
1112 - Oncology and Carcinogenesis >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2328/11131

Title: K-ras mutations and benefit from Cetuximab in advanced colorectal cancer
Authors: Au, Heather-Jane
Karapetis, Christos Stelios
Khambata-Ford, Shirin
Jonker, Derek
Tu, Dongsheng
Tebbutt, Niall C.
Price, Timothy J
Simes, R. John
Chalchal, Haji
Shapiro, Jeremy D.
Langer, Christiane
Moore, Malcolm J.
Zalcberg, John R.
Robitaille, Sonia
Shepherd, Lois
O'Callaghan, Chris J
Issue Date: 2008
Citation: Karapetis, C.S., Khambata-Ford, S., Jonker, D., O'Callaghan, C.j., Tu, D., Tebbutt, N.C., Simes, R.J., Chalchal, H., Shapiro, J.D., Robitaille, S., et al., 2008. K-ras mutations and benefit from Cetuximab in advanced colorectal cancer. New England Journal of Medicine, 359(17), 1757-1765.
URI: http://hdl.handle.net/2328/11131
ISSN: 0028-4793
Appears in Collections:1112 - Oncology and Carcinogenesis
1112 - Oncology and Carcinogenesis

Files in This Item:

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback